ZA94891B - Heteroaromatic compounds - Google Patents

Heteroaromatic compounds

Info

Publication number
ZA94891B
ZA94891B ZA94891A ZA94891A ZA94891B ZA 94891 B ZA94891 B ZA 94891B ZA 94891 A ZA94891 A ZA 94891A ZA 94891 A ZA94891 A ZA 94891A ZA 94891 B ZA94891 B ZA 94891B
Authority
ZA
South Africa
Prior art keywords
heteroaromatic compounds
heteroaromatic
compounds
Prior art date
Application number
ZA94891A
Other languages
English (en)
Inventor
Mark Henry Norman
Frank Navas Iii
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA94891B publication Critical patent/ZA94891B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA94891A 1993-02-10 1994-02-09 Heteroaromatic compounds ZA94891B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939302622A GB9302622D0 (en) 1993-02-10 1993-02-10 Heteroaromatic compounds

Publications (1)

Publication Number Publication Date
ZA94891B true ZA94891B (en) 1995-08-10

Family

ID=10730183

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA94891A ZA94891B (en) 1993-02-10 1994-02-09 Heteroaromatic compounds

Country Status (15)

Country Link
EP (1) EP0683778A1 (hu)
JP (1) JPH08506337A (hu)
CN (1) CN1117731A (hu)
AU (1) AU6005194A (hu)
BG (1) BG99839A (hu)
CA (1) CA2155758A1 (hu)
CZ (1) CZ204495A3 (hu)
FI (1) FI953777A (hu)
GB (1) GB9302622D0 (hu)
HU (1) HUT73654A (hu)
IL (1) IL108601A0 (hu)
MX (1) MX9401080A (hu)
SK (1) SK99195A3 (hu)
WO (1) WO1994018196A1 (hu)
ZA (1) ZA94891B (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5364866A (en) 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
ES2170177T3 (es) * 1995-03-17 2002-08-01 Aventis Pharma Inc Benzotienilpiperazinas sustituidas, su uso como medicamentos y procedimientos para su preparacion.
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
WO2002039988A2 (en) * 2000-11-14 2002-05-23 Merck Patent Gmbh Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
EP1361875A2 (en) * 2001-02-16 2003-11-19 Aventis Pharmaceuticals Inc. Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
HUP0402092A3 (en) 2001-07-26 2010-06-28 Merck Patent Gmbh Use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts for preparation of pharmaceutical compositions
GB0222909D0 (en) * 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
GB0222912D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
BRPI0511993A (pt) * 2004-07-20 2008-01-22 Siena Biotech Spa compostos moduladores de receptores de acetilcolina nicotìnicos alfa7, composições farmacêuticas e usos terapêuticos dos mesmos
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them
US8981095B2 (en) 2011-07-28 2015-03-17 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of lurasidone and salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625181B2 (ja) * 1985-03-27 1994-04-06 住友製薬株式会社 新規なイミド誘導体
AU593194B2 (en) * 1986-09-26 1990-02-01 Sumitomo Pharmaceuticals Company, Limited Imide derivatives ,and their production and use
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
MX9201991A (es) * 1991-05-02 1992-11-01 Jonh Wyeth & Brother Limited Derivados de piperazina y procedimiento para su preparacion.

Also Published As

Publication number Publication date
CA2155758A1 (en) 1994-08-18
JPH08506337A (ja) 1996-07-09
MX9401080A (es) 1994-08-31
SK99195A3 (en) 1995-12-06
IL108601A0 (en) 1994-05-30
CZ204495A3 (en) 1996-03-13
FI953777A0 (fi) 1995-08-09
AU6005194A (en) 1994-08-29
GB9302622D0 (en) 1993-03-24
HU9501881D0 (en) 1995-08-28
WO1994018196A1 (en) 1994-08-18
BG99839A (bg) 1996-02-28
CN1117731A (zh) 1996-02-28
EP0683778A1 (en) 1995-11-29
FI953777A (fi) 1995-08-09
HUT73654A (en) 1996-09-30

Similar Documents

Publication Publication Date Title
GB9306184D0 (en) Heteroaromatic compounds
GB9304620D0 (en) Compounds
GB9310978D0 (en) Compounds
GB9302622D0 (en) Heteroaromatic compounds
GB9302016D0 (en) Compounds
GB9315801D0 (en) Compounds
GB9313144D0 (en) Compounds
GB9307400D0 (en) Compounds
GB9315800D0 (en) Compounds
GB9317314D0 (en) Compounds
EP0733044A4 (en) CHEMICAL COMPOUNDS
GB9311766D0 (en) Compounds
GB9320186D0 (en) Compounds
GB9315154D0 (en) Hypolipademic compounds
GB9314966D0 (en) Compounds
GB9313185D0 (en) Compounds
GB9316954D0 (en) Compounds
GB9312688D0 (en) Compounds
GB9312687D0 (en) Compounds
GB9312686D0 (en) Compounds
GB9310425D0 (en) Compounds
GB9318198D0 (en) Compounds
GB9310597D0 (en) Compounds
GB9310595D0 (en) Compounds
GB9310594D0 (en) Compounds